CID 6444341
Rifamycin, 4-o-(2-(di-2-propenylamino)-2-oxoethyl)-
Structural Information
- Molecular Formula
- C45H58N2O13
- SMILES
- CC1/C=C/C=C(/C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(O/C=C/C(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)OCC(=O)N(CC=C)CC=C)\C
- InChI
- InChI=1S/C45H58N2O13/c1-12-18-47(19-13-2)33(49)22-57-32-21-30-40(53)35-34(32)36-42(28(8)39(35)52)60-45(10,43(36)54)58-20-17-31(56-11)25(5)41(59-29(9)48)27(7)38(51)26(6)37(50)23(3)15-14-16-24(4)44(55)46-30/h12-17,20-21,23,25-27,31,37-38,41,50-53H,1-2,18-19,22H2,3-11H3,(H,46,55)/b15-14+,20-17+,24-16+
- InChIKey
- MHTJOVRCLPHPDE-DKQCSNODSA-N
- Compound name
- [(9E,19E,21E)-27-[2-[bis(prop-2-enyl)amino]-2-oxoethoxy]-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 835.40114 | 277.0 |
[M+Na]+ | 857.38308 | 282.3 |
[M-H]- | 833.38658 | 274.4 |
[M+NH4]+ | 852.42768 | 278.0 |
[M+K]+ | 873.35702 | 268.1 |
[M+H-H2O]+ | 817.39112 | 262.3 |
[M+HCOO]- | 879.39206 | 279.0 |
[M+CH3COO]- | 893.40771 | 281.5 |
[M+Na-2H]- | 855.36853 | 282.8 |
[M]+ | 834.39331 | 291.3 |
[M]- | 834.39441 | 291.3 |
Literature stripe
No literature data available for this compound.
Patent stripe
No patent data available for this compound.